Key Points
-
Tularaemia is a highly infectious pathogen that is capable of causing a fatal disease, notably with doses that contain as few as 25 colony-forming units. This has made the organism that causes tularaemia, Francisella tularensis, attractive for use in biological weapons programmes.
-
Although a live vaccine strain has been used for many decades to immunize several thousand individuals, this vaccine is not licensed and is unlikely to prove licensable given current regulatory constraints. There is a need to develop a safe and licensable vaccine to protect against tularemia, particularly the pneumonic form of the disease.
-
F. tularensis is an intracellular pathogen that multiplies within macrophages and amoebae, resulting in high titres of bacteria. However, little is known about the mechanisms that this bacterium uses to adapt to and exploit the intracellular environment.
-
The epidemiology and geographical incidence of F. tularensis, and the typical clinical features of the disease — which can depend on the route of infection — are reviewed here.
-
The availability of genome sequence data for the vaccine strain and a virulent isolate of F. tularensis should facilitate development of a new vaccine. However, progress is still hampered by a lack of genetic tools for F. tularensis.
-
Approaches to develop a new vaccine might involve the identification of a specific subunit for use in a vaccine, or the production of a live attenuated strain. However, subunits must be delivered in a suitable conformation to induce a protective immune response.
Abstract
Francisella tularensis is a highly infectious aerosolizable intracellular pathogen that is capable of causing a debilitating or fatal disease with doses as low as 25 colony-forming units. There is no licensed vaccine available. Since the 1950s there has been concern that F. tularensis could be used as a biological threat agent, and it has received renewed attention recently owing to concerns about bioterrorism. The International Conference on Tularaemia in 2003 attracted more than 200 delegates, twice the number of participants as previous meetings. This is a reflection of the increased funding of research on this pathogen, particularly in the United States.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harris, S. Japanese biological warfare research on humans: a case study of microbiology and ethics. Ann. NY Acad. Sci. 666, 21–52 (1992).
Dennis, D. T. et al. Tularemia as a biological weapon — medical and public health management. JAMA 285, 2763–2773 (2001).
Alibek, K. Biohazard (Random House, New York, 1999).
World Health Organization. Health Aspects of Chemical and Biological Weapons (WHO, Geneva, 1970).
Riley, R. L. Aerial dissemination of pulmonary tuberculosis. Am. Rev. Tuberc. 76, 931–941 (1957).
Ellis, J., Oyston, P. C. F., Green, M. & Titball, R. W. Tularemia. Clin. Microbiol. Rev. 15, 631–646 (2002).
Titball, R. W. & Sjostedt, A. Francisella tularensis: an overview. ASM News 69, 558 (2003).
Titball, R. W., Johansson, A. & Forsman, M. Will the enigma of Francisella tularensis virulence soon be solved? Trends Microbiol. 11, 118–123 (2003).
Dorofe'ev, K. A. Classification of the causative agent of tularemia. Symp. Res. Works Inst. Epidemiol. Mikrobiol. Chita. 1, 170–180 (1947).
Broekhuijsen, M. et al. Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp tularensis. J. Clin. Microbiol. 41, 2924–2931 (2003). First (and so far only) comparative genomics publication on F. tularensis.
Thomas, R. et al. Discrimination of human pathogenic subspecies of Francisella tularensis by using restriction fragment length polymorphism. J. Clin. Microbiol. 41, 50–57 (2003).
Prior, R. G. et al. Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. J. Appl. Microbiol. 91, 614–620 (2001).
Morner, T. The ecology of tularemia. Rev. Sci. Tech. 11, 1123–1130 (1992).
Tärnvik, A., Sandström, G. & Sjöstedt, A. Epidemiological analysis of tularemia in Sweden 1931–1993. FEMS Immunol. Med. Microbiol. 13, 201–204 (1996).
Helvaci, S., Gedikoglu, S., Akalin, H. & Oral, H. B. Tularemia in Bursa, Turkey: 205 cases in ten years. Eur. J. Epidemiol. 16, 271–276 (2000).
Berdal, B. P. et al. Field detection of Francisella tularensis. Scand. J. Infect. Dis. 32, 287–291 (2000).
de Tuesta, A. M. D. et al. An epidemic outbreak of tularemia in the province of Cuenca linked with crab-fish handling. Rev. Clin. Esp. 201, 385–389 (2001).
Abd, H., Johansson, T., Golovliov, I., Sandstrom, G. & Forsman, M. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl. Environ. Microbiol. 69, 600–606 (2003). First demonstration of the ability of F. tularensis to grow in amoebae.
Lauriano, C. M. et al. MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc. Natl Acad. Sci. USA 101, 4246–4249 (2004). Showed a connection between the virulence mechanisms required for F. tularensis survival in eukaryotic cells and amoebae.
CDC. Tularemia — United States, 1990–2000. MMWR Morb. Mortal. Wkly Rep. 51, 181–184 (2002).
Whipp, M. J. et al. Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia. J. Med. Microbiol. 52, 839–842 (2003). First isolation of Francisella in Australia, indicating that the geographical range of the organism might be much larger than previously indicated.
Hopla, C. E. The ecology of tularemia. Adv. Vet. Sci. Comp. Med. 18, 25–53 (1974).
Sjöstedt, A. in Bergey's Manual of Systematic Bacteriology. (ed. Brenner, D. J.) (Springer, 2004).
Olsufev, N. G. Results and perspectives of the study of natural foci of tularemia in USSR. Med. Parazitol. (Mosk) 46, 273–82 (1977) (in Russian).
Morner, T. The ecology of tularemia. Rev. Sci. Tech. 11, 1123–1130 (1992).
Quijada, S. G. et al. Tularemia: study of 27 patients. Med. Clin. 119, 455–457 (2002).
Eliasson, H. et al. The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg. Infect. Dis. 8, 956–960 (2002).
Olin, G. Occurrence and mode of transmission of tularemia in Sweden. Acta Microbiol. Scand. 19, 220–247 (1942).
Hubalek, Z. & Halouzka, J. Mosquitoes (Diptera: Culicidae), in contrast to ticks (Acari: Ixodidae), do not carry Francisella tularensis in a natural focus of tularemia in the Czech Republic. J. Med. Entomol. 34, 660–663 (1997).
Olsufiev, N. G. in Human Diseases With Natural Foci (ed. Pavlovsky, Y. N.) 219–281 (Foreign Languages Publishing House, Moscow, 1966).
Boyce, J. M. Recent trends in the epidemiology of tularemia in the United States. J. Infect. Dis. 131, 197–199 (1975).
Christenson, B. An outbreak of tularemia in the northern part of central Sweden. Scand. J. Infect. Dis. 16, 285–290 (1984).
Evans, M. E., Gregory, D. W., Schaffner, W. & McGee, Z. A. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64, 251–269 (1985).
Tärnvik, A. & Berglund, L. Tularaemia. Eur. Respir. J. 21, 361–373 (2003).
Kavanaugh, C. N. Tularemia. A consideration of one hundred and twenty-three cases, with observations at autopsy in one. Arch. Intern. Med. 55, 61–85 (1935).
Dahlstrand, S., Ringertz, O. & Zetterberg, B. Airborne tularemia in Sweden. Scand. J. Infect. Dis. 3, 7–16 (1971).
Dienst, J., F. T. Tularemia — a perusal of three hundred thirty-nine cases. J. La State Med. Soc. 115, 114–127 (1963).
Anthony, L. S. D., Burke, R. D. & Nano, F. E. Growth of Francisella spp. in rodent macrophages. Infect. Immun. 59, 3291–3296 (1991).
Lofgren, S., Tarnvik, A., Bloom, G. D. & Sjoberg, W. Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect. Immun. 39, 715–720 (1983).
Lofgren, S., Tarnvik, A., Thore, M. & Carlsson, J. A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid — a possible explanation of their different handling by polymorphonuclear leukocytes. Infect. Immun. 43, 730–734 (1984).
Fortier, A. H. et al. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol. Serol. 349–361 (1994).
Reilly, T. J., Baron, G. S., Nano, F. E. & Kuhlenschmidt, M. S. Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis. J. Biol. Chem. 271, 10973–10983 (1996).
Baron, G. S., Reilly, T. J. & Nano, F. E. The respiratory burst-inhibiting acid phosphatase AcpA is not essential for the intramacrophage growth or virulence of Francisella novicida. FEMS Microbiol. Lett. 176, 85–90 (1999).
Fortier, A. H. et al. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect. Immun. 63, 1478–1483 (1995).
Ley, V., Robbins, E. S., Nussenzweig, V. & Andrews, N. W. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J. Exp. Med. 171, 401–413 (1990).
Clemens, D. L., Lee, B. -Y. & Horowitz, M. A. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Infect. Immun. 72, 3204–3217 (2004). Added greatly to the understanding of the intracellular events during infection.
Fortier, A. H., Polsinelli, T., Green, S. J. & Nacy, C. A. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells and effector molecules. Infect. Immun. 60, 817–825 (1992).
Polsinelli, T., Meltzer, M. S. & Fortier, A. H. Nitric oxide-independent killing of Francisella tularensis by IFN-γ-stimulated murine alveolar macrophages. J. Immunol. 153, 1238–1245 (1994).
Anthony, L. S. D., Morrissey, P. J. & Nano, F. E. Growth inhibition of Francisella tularensis live vaccine strain by IFNγ-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J. Immunol. 148, 1829–1834 (1992).
Elkins, K. L., Cowley, S. C. & Bosio, C. M. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5, 135–142 (2003).
Golovliov, I., Baranov, V., Krocova, Z., Kovarova, H. & Sjostedt, A. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Infect. Immun. 71, 5940–5950 (2003). Provided a novel view of the intracellular survival strategy of F. tularensis.
Berger, K. H. & Isberg, R. R. 2 distinct defects in intracellular growth complemented by a single genetic-locus in Legionella pneumophila. Mol. Microbiol. 7, 7–19 (1993).
Zamboni, D. S., McGrath, S., Rabinovitch, M. & Roy, C. R. Coxiella burnetii express type IV secretion system proteins that function similarly to components of the Legionella pneumophila Dot/Icm system. Mol. Microbiol. 49, 965–976 (2003).
Zusman, T., Yerushalmi, G. & Segal, G. Functional similarities between the icm/dot pathogenesis systems of Coxiella burnetii and Legionella pneumophila. Infect. Immun. 71, 3714–3723 (2003).
Lai, X. H., Golovliov, I. & Sjostedt, A. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect. Immun. 69, 4691–4694 (2001).
Lai, X. H. & Sjostedt, A. Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect. Immun. 71, 4642–4646 (2003).
Gao, L. Y. & Kwaik, Y. A. The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol. 8, 306–313 (2000).
Abd, H., Johansson, T., Golovliov, I., Sandstrom, G. & Forsman, M. Survival and growth of Francisella tularensis in Acanthamoeba castellanii. Appl. Environ. Microbiol. 69, 600–606 (2003).
Forestal, C. A. et al. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J. Immunol. 171, 2563–2570 (2003).
Golovliov, I., Ericsson, M., Sandstrom, G., Tarnvik, A. & Sjostedt, A. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect. Immun. 65, 2183–2189 (1997).
Telepnev, M., Golovliov, I., Grundstrom, T., Tarnvik, A. & Sjostedt, A. Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-α and IL-1 from murine macrophages. Cell. Microbiol. 5, 41–51 (2003).
Gray, C. G., Cowley, S. C., Cheung, K. K. M. & Nano, F. E. The identification of five genetic loci of Francisella novicida associated with intracellular growth. FEMS Microbiol. Lett. 215, 53–56 (2002).
Harb, O. S., Gao, L. Y. & Abu Kwaik, Y. From protozoa to mammalian cells: a new paradigm in the life cycle of intracellular bacterial pathogens. Environ. Microbiol. 2, 251–265 (2000).
Nano, F. E. et al. A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186, 6430–6436 (2004).
Anthony, L. S. D., Cowley, S. C., Mdluli, K. E. & Nano, F. E. Isolation of a Francisella tularensis mutant that is sensitive to serum and oxidative killing and is avirulent in mice: correlation with the loss of MinD homologue expression. FEMS Microbiol. Lett. 124, 157–166 (1994).
Sandstrom, G., Lofgren, S. & Tarnvik, A. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56, 1194–1202 (1988).
Sorokin, V. M., Pavlov, V. M. & Prozorova, L. A. Francisella tularensis resistance to bactericidal action of normal human serum. FEMS Immunol. Med. Microbiol. 13, 249–252 (1996).
Prior, J. L. et al. Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp tularensis. J. Med. Microbiol. 52, 845–851 (2003).
Vinogradov, E., Conlan, W. J., Gunn, J. S. & Perry, M. B. Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr. Res. 339, 649–654 (2004).
McDonald, M. K., Cowley, S. C. & Nano, F. E. Temperature-sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature. J. Bacteriol. 179, 7638–7643 (1997).
Mdluli, K. E. et al. Serum sensitive mutation of Francisella novicida association with an ABC transporter gene. Microbiology 140, 3309–3318 (1994).
Sandstrom, G., Sjostedt, A., Johansson, T., Kuoppa, K. & Williams, J. C. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 5, 201–210 (1992).
Eigelsbach, H. T., Braun, W. & Herring, R. D. Studies on the variation of Bacterium tularense. J. Bacteriol. 61, 557–569 (1951).
Cowley, S. C., Myltseva, S. V. & Nano, F. E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20, 867–874 (1996). Describes an unusual antigenic switch that might contribute to the pathogenicity of F. tularensis.
Lauriano, C. M., Barker, J. R., Nano, F. E., Arulanandarn, B. P. & Klose, K. E. Allelic exchange in Francisella tularensis using PCR products. FEMS Microbiol. Lett. 229, 195–202 (2003).
Gil, H., Benach, J. L. & Thanassi, D. G. Presence of pili on the surface of Francisella tularensis. Infect. Immun. 72, 3042–3047 (2004).
Craig, L., Pique, M. E. & Tainer, J. A. Type IV pilus structure and bacterial pathogenicity. Nature Rev. Microbiol. 2, 363–378 (2004).
Ancuta, P., Pedron, T., Girard, R., Sandstrom, G. & Chaby, R. Inability of Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect. Immun. 64, 2041–2046 (1996).
Golovliov, I., Kuoppa, K., Sjostedt, A., Tarnvik, A. & Sandstrom, G. Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol. Med. Microbiol. 13, 239–244 (1996).
Golovliov, I., Sandstrom, G., Ericsson, M., Sjostedt, A. & Tarnvik, A. Cytokine expression in the liver during the early phase of murine tularemia. Infect. Immun. 63, 534–538 (1995).
Elkins, K. L., Leiby, D. A., Winegar, R. K., Nacy, C. A. & Fortier, A. H. Rapid generation of specific protective immunity to Francisella tularensis. Infect. Immun. 60, 4571–4577 (1992).
Elkins, K. L., Rhinehart-Jones, T., Nacy, C. A., Winegar, R. K. & Fortier, A. H. T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect. Immun. 61, 823–829 (1993).
Conlan, J. W., Sjostedt, A. & North, R. J. CD4+ and CD8+ T-cell-dependent and -independent host defence mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect. Immun. 62, 5603–5607 (1994).
Yee, D., Rhinehart-Jones, T. R. & Elkins, K. L. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 157, 5042–5048 (1996).
Fulop, M., Mastroeni, P., Green, M. & Titball, R. W. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19, 4465–4472 (2001).
Sumida, T. et al. Predominant expansion of V γ 9/V δ2 T cells in a tularemia patient. Infect. Immun. 60, 2554–2558 (1992).
Kroca, M., Tarnvik, A. & Sjostedt, A. The proportion of circulating γδ T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin. Exp. Immunol. 120, 280–284 (2000).
Eigelsbach, H. T., Hornick, R. B. & Tulis, J. J. Recent studies on live tularemia vaccine. Med. Ann. Dist. Columbia 36, 282–286 (1967).
Burke, D. S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory acquired tularemia. J. Infect. Dis. 135, 55–60 (1977).
Karlsson, J. et al. Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. Microb. Comp. Genomics 5, 25–39 (2000). Preliminary analysis of the first genome sequence of F. tularensis.
Tarnvik, A. Nature of protective immunity to Francisella tularensis. Rev. Infect. Dis. 11, 440–451 (1989).
Fulop, M., Manchee, R. & Titball, R. Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence. FEMS Immunol. Med. Microbiol. 13, 245–247 (1996).
Conlan, J. W., Shen, H., Webb, A. & Perry, M. B. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20, 3465–3471 (2002). References 85 and 93 show the prerequisites for protection differ between low- and high-virulence strains of F. tularensis
Titball, R. W. & Oyston, P. C. F. A vaccine for tularaemia. Expert Opin. Biol. Ther. 3, 1–9 (2003).
Bevanger, L., Maeland, J. A. & Naess, A. I. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of Tularemia. J. Clin. Microbiol. 26, 433–437 (1988).
Havlasova, J. et al. Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain. Proteomics 2, 857–867 (2002). First description of the proteome of F. tularensis.
Ericsson, M., Kroca, M., Johansson, T., Sjostedt, A. & Tarnvik, A. Long-lasting recall response of CD4+ and CD8+ αβ T cells, but not γδ T cells, to heat shock proteins of Francisella tularensis. Scand. J. Infect. Dis. 33, 145–152 (2001).
Sjostedt, A., Sandstrom, G. & Tarnvik, A. Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J. Clin. Microbiol. 28, 43–48 (1990).
Sjostedt, A., Sandstrom, G. & Tarnvik, A. Humoral and cell-mediated-immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect. Immun. 60, 2855–2862 (1992).
Ikaheimo, I., Syrjala, H., Karhukorpi, J., Schildt, R. & Koskela, M. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J. Antimicrob. Chemother. 46, 287–290 (2000).
Enderlin, G., Morales, L., Jacobs, R. F. & Cross, J. T. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin. Infect. Dis. 19, 42–47 (1994).
Johansson, A., Urich, S. K., Chu, M. C., Sjöstedt, A. & Tärnvik, A. In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis. Scand. J. Infect. Dis. 34, 327–330 (2002).
Johansson, A., Berglund, L., Gothefors, L., Sjostedt, A. & Tarnvik, A. Ciprofloxacin for treatment of tularemia in children. Pediatr. Infect. Dis. J. 19, 449–453 (2000).
Perez-Castrillon, J. L., Bachiller-Luque, P., Martin-Luquero, M., Mena-Martin, F. J. & Herreros, V. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin.Infect. Dis. 33, 573–6 (2001).
Petersen, J. M. et al. Laboratory analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 2002. Emerg. Infect. Dis. 10, 419–425 (2004).
Avashia, S. B. et al. First reported prairie dog-to-human tularemia transmission, Texas, 2002. Emerg. Infect. Dis. 10, 483–486 (2004).
Feldman, K. A. et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N. Engl J. Med. 345, 1601–1606 (2001).
Feldman, K. A. et al. Tularemia on Martha's Vineyard: seroprevalence and occupational risk. Emerg. Infect. Dis. 9, 350–354 (2003).
Chien, M. et al. The genomic sequence of the accidental pathogen Legionella pneumophila. Science. 305, 1966–1968 (2004).
Lindgren, H. et al. Factors affecting the escape of Francisella tularensis from the phagolysosome. J. Med. Microbiol. 53, 953–958 (2004).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Related links
DATABASES
Infectious Disease Information
FURTHER INFORMATION
Glossary
- ENZOOTIC
-
Relating to a zoonotic infection, usually used in the context of a geographical area.
- ZOONOSIS
-
An infection that is transmitted between lower vertebrates and humans.
- LAGOMORPH
-
Any placental mammal with furred feet and two pairs of upper incisors that are specialized for gnawing, such as hares, rabbits and pikas.
- SUPPURATION
-
The formation or discharge of pus. An abscess is a localized area of suppuration.
- MACROPHAGE
-
A cell of the mononuclear phagocyte system that is responsible for phagocytosis of foreign material.
- PHAGOSOME
-
A vesicle that is formed by invagination of plasma membranes during endocytosis. Vesicles containing lysozyme then fuse with the phagosome to degrade engulfed material.
- CYTOKINES
-
Small proteins that are important for immunity and inflammation and that act on effector cells of the immune system.
- OTOTOXICITY
-
Having a toxic effect on the structures of the ear, especially on its nerve supply.
Rights and permissions
About this article
Cite this article
Oyston, P., Sjöstedt, A. & Titball, R. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2, 967–978 (2004). https://doi.org/10.1038/nrmicro1045
Issue Date:
DOI: https://doi.org/10.1038/nrmicro1045
This article is cited by
-
Development of a novel glycoengineering platform for the rapid production of conjugate vaccines
Microbial Cell Factories (2023)
-
Therapierefraktäre Lymphadenopathie nach Genuss von Milchprodukten
HNO (2023)
-
Tularemia research activity: a bibliometric analysis between 1980 and 2020
Infection (2022)
-
Structural and functional analysis of the Francisella lysine decarboxylase as a key actor in oxidative stress resistance
Scientific Reports (2021)
-
Lymph node abscess caused by Francisella tularensis – a rare differential diagnosis for cervical lymph node swelling: a case report
Journal of Medical Case Reports (2019)